ArraVasc creates innovative devices for interventional clinicians.
The Company has developed a range of unique endovascular platform technologies that have delivered a stream of world-class devices with a focus on peripheral vascular disease. Their R&D team is developing a range of novel solutions for some of the more challenging clinical cases in this disease area – the long, tough lesions often found in late-stage peripheral artery disease (PAD), whilst minimising trauma to the patient and helping speed up procedure times.
ArraVasc has also developed novel access technologies for the treatment of complex coronary artery disease (Sideguard) – with its innovative nitinol stent design and ‘Peel Away Sheath’ delivery system. The Sideguard has a CE mark with extensive clinical research completed.